LC-MS/MS analysis and comparison of oxidative damages on peptides induced by pathogen reduction technologies for platelets.
Pathogen reduction technologies (PRT) are photochemical processes that use a combination of photosensitizers and UV-light to inactivate pathogens in platelet concentrates (PCs), a blood-derived product used to prevent hemorrhage. However, different studies have questioned the impact of PRT on platelet function and transfusion efficacy, and several proteomic analyses revealed possible oxidative damages to proteins. The present work focused on the oxidative damages produced by the two main PRT on peptides. Model peptides containing residues prone to oxidation (tyrosine, histidine, tryptophane, and cysteine) were irradiated with a combination of amotosalen/UVA (Intercept process) or riboflavin/UVB (Mirasol-like process). Modifications were identified and quantified by liquid chromatography coupled to tandem mass spectrometry. Cysteine-containing peptides formed disulfide bridges (R-SS-R, -2 Da; favored following amotosalen/UVA), sulfenic and sulfonic acids (R-SOH, +16 Da, R-SO3H, +48 Da, favored following riboflavin/UVB) upon treatment and the other amino acids exhibited different oxidations revealed by mass shifts from +4 to +34 Da involving different mechanisms; no photoadducts were detected. These amino acids were not equally affected by the PRT and the combination riboflavin/UVB generated more oxidation than amotosalen/UVA. This work identifies the different types and sites of peptide oxidations under the photochemical treatments and demonstrates that the two PRT may behave differently. The potential impact on proteins and platelet functions may thus be PRT-dependent.
Service Régional Vaudois de Transfusion Sanguine, Unité de Recherche et Développement, Lausanne, Switzerland.
Michel
M
Prudent
Giona
G
Sonego
Mélanie
M
Abonnenc
Jean-Daniel
JD
Tissot
Niels
N
Lion
D000890:Anti-Infective Agents / Q000494:pharmacology; D001792:Blood Platelets / Q000382:microbiology; D002853:Chromatography, Liquid / Q000379:methods*; D011564:Furocoumarins / Q000494:pharmacology; D010084:Oxidation-Reduction / Q000187:drug effects / Q000528:radiation effects; D010455:Peptides / Q000032:analysis / Q000737:chemistry / Q000187:drug effects / Q000528:radiation effects; D017319:Photosensitizing Agents / Q000494:pharmacology; D053719:Tandem Mass Spectrometry / Q000379:methods*; D014466:Ultraviolet Rays
D000890:Anti-Infective Agents; D011564:Furocoumarins; D010455:Peptides; D017319:Photosensitizing Agents; C118577:amotosalen